Company Name:Celgene Corporation
CEO: Mark J. Alles

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.


Key numbers

Market Capitalization:
Shares Outstanding: 0
Float:
Next Earning Date:
TTm EPS:
TTm Dividend Rate:
200 days moving average:95.6
50 days moving average: 103.23
One day percent Change: -1.62



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,